Inovio Pharmaceuticals, Inc. (INO)
USD 1.46
(-7.59%)
USD 1.46
(-7.59%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 | -135.22 Million USD | 49.46% |
| 2022 | -267.57 Million USD | 11.17% |
| 2021 | -301.21 Million USD | -142.76% |
| 2020 | -124.08 Million USD | -11.68% |
| 2019 | -111.1 Million USD | -18.09% |
| 2018 | -94.09 Million USD | -12.49% |
| 2017 | -83.64 Million USD | -9.72% |
| 2016 | -76.23 Million USD | -122.37% |
| 2015 | -34.28 Million USD | 13.2% |
| 2014 | -39.49 Million USD | -102.08% |
| 2013 | -19.54 Million USD | 16.81% |
| 2012 | -23.49 Million USD | -8.57% |
| 2011 | -21.63 Million USD | -12.58% |
| 2010 | -19.22 Million USD | -37.7% |
| 2009 | -13.95 Million USD | -2.19% |
| 2008 | -13.65 Million USD | 14.09% |
| 2007 | -15.89 Million USD | -19.12% |
| 2006 | -13.34 Million USD | 13.93% |
| 2005 | -15.5 Million USD | -34.72% |
| 2004 | -11.51 Million USD | -73.53% |
| 2003 | -6.63 Million USD | -11.77% |
| 2002 | -5.93 Million USD | -6.44% |
| 2001 | -5.57 Million USD | 41.52% |
| 2000 | -9.53 Million USD | -38.18% |
| 1999 | -6.9 Million USD | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q2 | -33.19 Million USD | -5.44% |
| 2024 Q1 | -31.48 Million USD | -14.93% |
| 2023 FY | -135.22 Million USD | 49.46% |
| 2023 Q1 | -43.95 Million USD | 21.44% |
| 2023 Q3 | -35.55 Million USD | 4.02% |
| 2023 Q4 | -27.39 Million USD | 22.95% |
| 2023 Q2 | -37.04 Million USD | 15.72% |
| 2022 Q4 | -55.94 Million USD | -56.46% |
| 2022 Q3 | -35.75 Million USD | 65.66% |
| 2022 Q1 | -71.73 Million USD | 32.01% |
| 2022 Q2 | -104.13 Million USD | -45.17% |
| 2022 FY | -267.57 Million USD | 11.17% |
| 2021 Q3 | -59.95 Million USD | 27.94% |
| 2021 Q1 | -52.55 Million USD | -79.13% |
| 2021 Q4 | -105.5 Million USD | -75.98% |
| 2021 FY | -301.21 Million USD | -142.76% |
| 2021 Q2 | -83.2 Million USD | -58.32% |
| 2020 Q3 | -36.32 Million USD | -9.49% |
| 2020 Q2 | -33.18 Million USD | -31.5% |
| 2020 Q4 | -29.33 Million USD | 19.24% |
| 2020 FY | -124.08 Million USD | -11.68% |
| 2020 Q1 | -25.23 Million USD | 17.06% |
| 2019 Q2 | -28.2 Million USD | 1.17% |
| 2019 Q1 | -28.53 Million USD | 3.27% |
| 2019 Q3 | -23.95 Million USD | 15.07% |
| 2019 Q4 | -30.42 Million USD | -27.01% |
| 2019 FY | -111.1 Million USD | -18.09% |
| 2018 Q2 | -5.2 Million USD | 84.11% |
| 2018 FY | -94.09 Million USD | -12.49% |
| 2018 Q1 | -32.74 Million USD | -43.07% |
| 2018 Q3 | -26.64 Million USD | -412.05% |
| 2018 Q4 | -29.49 Million USD | -10.72% |
| 2017 Q2 | -9.63 Million USD | 56.07% |
| 2017 Q4 | -22.88 Million USD | 21.58% |
| 2017 FY | -83.64 Million USD | -9.72% |
| 2017 Q1 | -21.93 Million USD | 1.92% |
| 2017 Q3 | -29.18 Million USD | -202.89% |
| 2016 Q3 | -20.19 Million USD | -10.8% |
| 2016 Q2 | -18.22 Million USD | -17.97% |
| 2016 FY | -76.23 Million USD | -122.37% |
| 2016 Q4 | -22.36 Million USD | -10.73% |
| 2016 Q1 | -15.45 Million USD | -6.36% |
| 2015 FY | -34.28 Million USD | 13.2% |
| 2015 Q1 | -8.36 Million USD | 24.01% |
| 2015 Q2 | -15.12 Million USD | -80.7% |
| 2015 Q3 | 3.73 Million USD | 124.67% |
| 2015 Q4 | -14.52 Million USD | -489.4% |
| 2014 Q2 | -10.15 Million USD | -1.53% |
| 2014 Q1 | -10 Million USD | -24.94% |
| 2014 Q3 | -8.33 Million USD | 17.94% |
| 2014 Q4 | -11.01 Million USD | -32.18% |
| 2014 FY | -39.49 Million USD | -102.08% |
| 2013 Q2 | -5.67 Million USD | 14.5% |
| 2013 Q4 | -8 Million USD | -1145.38% |
| 2013 Q3 | 765.64 Thousand USD | 113.5% |
| 2013 FY | -19.54 Million USD | 16.81% |
| 2013 Q1 | -6.63 Million USD | -6.54% |
| 2012 Q3 | -6.29 Million USD | 7.31% |
| 2012 FY | -23.49 Million USD | -8.57% |
| 2012 Q1 | -4.18 Million USD | 27.56% |
| 2012 Q2 | -6.78 Million USD | -62.14% |
| 2012 Q4 | -6.22 Million USD | 1.03% |
| 2011 Q3 | -6.33 Million USD | -23.36% |
| 2011 Q4 | -5.77 Million USD | 8.79% |
| 2011 FY | -21.63 Million USD | -12.58% |
| 2011 Q1 | -4.63 Million USD | 12.21% |
| 2011 Q2 | -5.13 Million USD | -10.8% |
| 2010 Q1 | -4.4 Million USD | -15.66% |
| 2010 Q4 | -5.28 Million USD | -15.88% |
| 2010 Q3 | -4.55 Million USD | 8.43% |
| 2010 Q2 | -4.97 Million USD | -12.9% |
| 2010 FY | -19.22 Million USD | -37.7% |
| 2009 Q3 | -3.59 Million USD | -20.26% |
| 2009 FY | -13.95 Million USD | -2.19% |
| 2009 Q2 | -2.99 Million USD | 16.01% |
| 2009 Q1 | -3.56 Million USD | -2.85% |
| 2009 Q4 | -3.81 Million USD | -5.96% |
| 2008 Q1 | -3.34 Million USD | -84.72% |
| 2008 FY | -13.65 Million USD | 14.09% |
| 2008 Q4 | -3.46 Million USD | -25.94% |
| 2008 Q3 | -2.74 Million USD | 33.0% |
| 2008 Q2 | -4.1 Million USD | -22.61% |
| 2007 FY | -15.89 Million USD | -19.12% |
| 2007 Q2 | -4.75 Million USD | -10.53% |
| 2007 Q1 | -4.3 Million USD | -13.44% |
| 2007 Q3 | -5.02 Million USD | -5.67% |
| 2007 Q4 | -1.81 Million USD | 63.96% |
| 2006 Q3 | -3.53 Million USD | -10.43% |
| 2006 Q2 | -3.2 Million USD | -13.86% |
| 2006 FY | -13.34 Million USD | 13.93% |
| 2006 Q1 | -2.81 Million USD | 8.3% |
| 2006 Q4 | -3.79 Million USD | -7.27% |
| 2005 FY | -15.5 Million USD | -34.72% |
| 2005 Q1 | -7.22 Million USD | -85.77% |
| 2005 Q2 | -2.18 Million USD | 69.74% |
| 2005 Q3 | -3.03 Million USD | -38.81% |
| 2005 Q4 | -3.06 Million USD | -1.13% |
| 2004 Q4 | -3.88 Million USD | -9.74% |
| 2004 Q3 | -3.54 Million USD | -43.68% |
| 2004 FY | -11.51 Million USD | -73.53% |
| 2004 Q2 | -2.46 Million USD | -52.49% |
| 2004 Q1 | -1.61 Million USD | 10.58% |
| 2003 Q1 | -1.74 Million USD | -21.02% |
| 2003 FY | -6.63 Million USD | -11.77% |
| 2003 Q4 | -1.8 Million USD | -6.51% |
| 2003 Q3 | -1.69 Million USD | -21.26% |
| 2003 Q2 | -1.39 Million USD | 19.8% |
| 2002 FY | -5.93 Million USD | -6.44% |
| 2002 Q4 | -1.44 Million USD | 2.04% |
| 2002 Q3 | -1.47 Million USD | 3.35% |
| 2002 Q2 | -1.52 Million USD | -3.92% |
| 2002 Q1 | -1.46 Million USD | -278.77% |
| 2001 Q1 | -3.24 Million USD | -43.26% |
| 2001 FY | -5.57 Million USD | 41.52% |
| 2001 Q4 | 819.92 Thousand USD | 148.0% |
| 2001 Q3 | -1.7 Million USD | 37.63% |
| 2001 Q2 | -2.73 Million USD | 15.69% |
| 2000 Q3 | -2.07 Million USD | -1.55% |
| 2000 Q1 | -2.53 Million USD | -40.81% |
| 2000 FY | -9.53 Million USD | -38.18% |
| 2000 Q4 | -2.26 Million USD | -9.43% |
| 2000 Q2 | -2.04 Million USD | 19.49% |
| 1999 Q1 | 1.1 Million USD | 134.38% |
| 1999 Q2 | -3 Million USD | -372.73% |
| 1999 FY | -6.9 Million USD | 0.0% |
| 1999 Q4 | -1.8 Million USD | 10.0% |
| 1999 Q3 | -2 Million USD | 33.33% |
| 1998 Q4 | -3.2 Million USD | 0.0% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| Akebia Therapeutics, Inc. | -46.25 Million USD | -192.344% |
| Jaguar Health, Inc. | -34.29 Million USD | -294.35% |
| Keros Therapeutics, Inc. | -169.94 Million USD | 20.427% |
| Longboard Pharmaceuticals, Inc. | -56.75 Million USD | -138.247% |
| Alnylam Pharmaceuticals, Inc. | -282.17 Million USD | 52.077% |
| Ligand Pharmaceuticals Incorporated | 11.94 Million USD | 1232.362% |
| ContextLogic Inc. | -328 Million USD | 58.772% |
| MiMedx Group, Inc. | 37.11 Million USD | 464.335% |
| MEI Pharma, Inc. | 14.54 Million USD | 1029.904% |
| AlloVir, Inc. | -181.33 Million USD | 25.426% |
| Novavax, Inc. | -566.51 Million USD | 76.13% |
| Aptorum Group Limited | -10.52 Million USD | -1185.018% |
| Ardelyx, Inc. | -63.27 Million USD | -113.709% |
| Arrowhead Pharmaceuticals, Inc. | -205 Million USD | 34.036% |
| Psyence Biomedical Ltd. | -2.75 Million USD | -4814.072% |
| Vaxcyte, Inc. | -468.04 Million USD | 71.108% |
| Precigen, Inc. | -88.92 Million USD | -52.072% |
| Pharming Group N.V. | -4.87 Million USD | -2671.297% |
| Phathom Pharmaceuticals, Inc. | -167.31 Million USD | 19.177% |
| Pieris Pharmaceuticals, Inc. | -29.75 Million USD | -354.452% |
| Rigel Pharmaceuticals, Inc. | -20.49 Million USD | -559.932% |
| Avidity Biosciences, Inc. | -235.59 Million USD | 42.603% |
| TransCode Therapeutics, Inc. | -19.41 Million USD | -596.38% |
| Reviva Pharmaceuticals Holdings, Inc. | -24.3 Million USD | -456.337% |
| Reviva Pharmaceuticals Holdings, Inc. | -24.3 Million USD | -456.337% |
| Bicycle Therapeutics plc | -189.94 Million USD | 28.808% |
| Sangamo Therapeutics, Inc. | -274 Million USD | 50.648% |
| Sol-Gel Technologies Ltd. | -29.3 Million USD | -361.446% |
| Acelyrin, Inc. | -422.06 Million USD | 67.961% |
| SELLAS Life Sciences Group, Inc. | -37.86 Million USD | -257.091% |
| Sensei Biotherapeutics, Inc. | -37.06 Million USD | -264.846% |
| Senti Biosciences, Inc. | -92.72 Million USD | -45.833% |
| Stoke Therapeutics, Inc. | -114.77 Million USD | -17.821% |
| AbCellera Biologics Inc. | -237.2 Million USD | 42.992% |
| Alaunos Therapeutics, Inc. | -34.26 Million USD | -294.626% |
| BioXcel Therapeutics, Inc. | -171.78 Million USD | 21.28% |
| Entrada Therapeutics, Inc. | -3.16 Million USD | -4176.618% |
| Chimerix, Inc. | -93.06 Million USD | -45.303% |
| VistaGen Therapeutics, Inc. | -33.02 Million USD | -309.517% |
| Windtree Therapeutics, Inc. | -17.53 Million USD | -671.006% |
| Corbus Pharmaceuticals Holdings, Inc. | -45.07 Million USD | -199.988% |
| Viracta Therapeutics, Inc. | -50.69 Million USD | -166.756% |
| Elevation Oncology, Inc. | -45.44 Million USD | -197.561% |
| Alkermes plc | 414.12 Million USD | 132.654% |
| Fortress Biotech, Inc. | -142.34 Million USD | 4.999% |
| Fortress Biotech, Inc. | -142.34 Million USD | 4.999% |
| Agenus Inc. | -159.54 Million USD | 15.244% |
| HOOKIPA Pharma Inc. | -97.69 Million USD | -38.419% |
| Dyadic International, Inc. | -8.22 Million USD | -1543.146% |
| ImmuCell Corporation | -5.74 Million USD | -2252.554% |
| Eton Pharmaceuticals, Inc. | -1.19 Million USD | -11244.518% |
| IDEAYA Biosciences, Inc. | -134.42 Million USD | -0.593% |
| Lantern Pharma Inc. | -17.87 Million USD | -656.404% |
| Immix Biopharma, Inc. | -16.14 Million USD | -737.778% |
| Incyte Corporation | 620.52 Million USD | 121.792% |
| IO Biotech, Inc. | -91.44 Million USD | -47.881% |
| Janux Therapeutics, Inc. | -72.97 Million USD | -85.295% |
| Inhibikase Therapeutics, Inc. | -20.08 Million USD | -573.111% |
| Outlook Therapeutics, Inc. | -53.12 Million USD | -154.538% |
| Syros Pharmaceuticals, Inc. | -128.98 Million USD | -4.837% |
| Kintara Therapeutics, Inc. | -8.5 Million USD | -1490.715% |
| Barinthus Biotherapeutics plc | -83.91 Million USD | -61.149% |
| Madrigal Pharmaceuticals, Inc. | -380.49 Million USD | 64.46% |
| Sorrento Therapeutics, Inc. | -504.31 Million USD | 73.186% |
| NextCure, Inc. | -67.63 Million USD | -99.93% |
| Ocuphire Pharma, Inc. | -10.56 Million USD | -1180.192% |
| Onconetix, Inc. | -36.03 Million USD | -275.269% |
| Oncternal Therapeutics, Inc. | -41.71 Million USD | -224.176% |
| Opthea Limited | -191.84 Million USD | 29.512% |
| PDS Biotechnology Corporation | -43.04 Million USD | -214.15% |
| PureTech Health plc | -146.19 Million USD | 7.505% |
| Pyxis Oncology, Inc. | -82.19 Million USD | -64.517% |
| Seer, Inc. | -103.46 Million USD | -30.7% |
| Salarius Pharmaceuticals, Inc. | -12.89 Thousand USD | -1048580.002% |
| Clearside Biomedical, Inc. | -24.84 Million USD | -444.303% |
| Telomir Pharmaceuticals, Inc. Common Stock | -3.94 Million USD | -3330.366% |
| VYNE Therapeutics Inc. | -29.25 Million USD | -362.187% |
| Wave Life Sciences Ltd. | -67.99 Million USD | -98.874% |
| Xeris Biopharma Holdings, Inc. | -44.01 Million USD | -207.263% |
| C4 Therapeutics, Inc. | -139.03 Million USD | 2.736% |
| ChromaDex Corporation | -5.59 Million USD | -2315.193% |
| TRACON Pharmaceuticals, Inc. | -6.89 Million USD | -1860.375% |
| Caribou Biosciences, Inc. | -116.05 Million USD | -16.515% |
| CRISPR Therapeutics AG | -222.53 Million USD | 39.234% |
| Precision BioSciences, Inc. | -43.73 Million USD | -209.188% |
| Fate Therapeutics, Inc. | -190.51 Million USD | 29.019% |
| Innoviva, Inc. | 176.7 Million USD | 176.525% |
| Summit Therapeutics Inc. | -89.73 Million USD | -50.694% |
| Verrica Pharmaceuticals Inc. | -65.75 Million USD | -105.64% |
| Aadi Bioscience, Inc. | -71.93 Million USD | -87.99% |
| ESSA Pharma Inc. | -32.13 Million USD | -320.82% |
| GlycoMimetics, Inc. | -39.27 Million USD | -244.305% |
| GT Biopharma, Inc. | -13.57 Million USD | -896.071% |
| Inhibrx Biosciences, Inc. | -219.22 Million USD | 38.315% |
| Catalyst Pharmaceuticals, Inc. | 86.81 Million USD | 255.77% |
| Orchestra BioMed Holdings, Inc. | -51.5 Million USD | -162.545% |
| Alzamend Neuro, Inc. | -9.93 Million USD | -1260.752% |
| Rocket Pharmaceuticals, Inc. | -259.65 Million USD | 47.921% |
| Aptose Biosciences Inc. | -52.35 Million USD | -158.283% |
| ZyVersa Therapeutics, Inc. | -14.42 Million USD | -837.721% |
| Soligenix, Inc. | -7.69 Million USD | -1656.66% |
| Century Therapeutics, Inc. | -146.54 Million USD | 7.724% |
| Kura Oncology, Inc. | -165.8 Million USD | 18.442% |
| TScan Therapeutics, Inc. | -93.45 Million USD | -44.692% |
| Intensity Therapeutics, Inc. | -8.31 Million USD | -1525.516% |
| Ocean Biomedical, Inc. | -2.48 Million USD | -5349.087% |
| CytomX Therapeutics, Inc. | -6.48 Million USD | -1985.544% |
| Autolus Therapeutics plc | -195.02 Million USD | 30.663% |
| Mineralys Therapeutics, Inc. | -84.65 Million USD | -59.735% |
| EyePoint Pharmaceuticals, Inc. | -73.66 Million USD | -83.577% |
| Eterna Therapeutics Inc. | -21.13 Million USD | -539.823% |
| Adaptive Biotechnologies Corporation | -227.03 Million USD | 40.438% |
| GRI Bio, Inc. | -11.38 Million USD | -1087.553% |
| Xenetic Biosciences, Inc. | -4.51 Million USD | -2894.579% |
| Tenaya Therapeutics, Inc. | -131.19 Million USD | -3.075% |
| IGM Biosciences, Inc. | -263.46 Million USD | 48.673% |
| INmune Bio, Inc. | -29.74 Million USD | -354.681% |
| Heron Therapeutics, Inc. | -110.61 Million USD | -22.25% |
| SAB Biotherapeutics, Inc. | -38.07 Million USD | -255.156% |
| Pasithea Therapeutics Corp. | -15.97 Million USD | -746.258% |
| Entero Therapeutics, Inc. | -15.77 Million USD | -757.448% |
| Milestone Pharmaceuticals Inc. | -61.09 Million USD | -121.327% |
| X4 Pharmaceuticals, Inc. | -107.52 Million USD | -25.767% |
| Atara Biotherapeutics, Inc. | -276 Million USD | 51.006% |
| Coherus BioSciences, Inc. | -203.19 Million USD | 33.451% |
| Verastem, Inc. | -92.08 Million USD | -46.851% |
| Abeona Therapeutics Inc. | -47.13 Million USD | -186.892% |
| Pliant Therapeutics, Inc. | -184.14 Million USD | 26.565% |
| Tonix Pharmaceuticals Holding Corp. | -118.38 Million USD | -14.231% |
| Histogen Inc. | -10.64 Million USD | -1170.569% |
| Aprea Therapeutics, Inc. | -15.47 Million USD | -774.011% |
| Surrozen, Inc. | -45.78 Million USD | -195.384% |
| Organovo Holdings, Inc. | -15.08 Million USD | -796.372% |
| Lixte Biotechnology Holdings, Inc. | -5.09 Million USD | -2556.589% |
| Ovid Therapeutics Inc. | -59.28 Million USD | -128.11% |
| Panbela Therapeutics, Inc. | -51.29 Million USD | -163.631% |
| CASI Pharmaceuticals, Inc. | -25.28 Million USD | -434.916% |
| Cadrenal Therapeutics, Inc. Common Stock | -7.63 Million USD | -1671.642% |
| Centessa Pharmaceuticals plc | -171.28 Million USD | 21.051% |
| Hepion Pharmaceuticals, Inc. | -48.44 Million USD | -179.117% |
| Arcturus Therapeutics Holdings Inc. | -78.2 Million USD | -72.913% |
| BioRestorative Therapies, Inc. | -15.22 Million USD | -788.435% |
| Apollomics, Inc. | -54.83 Million USD | -146.611% |
| Amarin Corporation plc | -67.58 Million USD | -100.075% |
| Mesoblast Limited | -58.79 Million USD | -130.001% |
| Turnstone Biologics Corp. | -59.03 Million USD | -129.073% |
| Kymera Therapeutics, Inc. | -165.53 Million USD | 18.307% |
| Synaptogenix, Inc. | -8.31 Million USD | -1526.522% |
| Tiziana Life Sciences Ltd | -14.58 Million USD | -827.099% |
| Aurinia Pharmaceuticals Inc. | -91.69 Million USD | -47.481% |
| BriaCell Therapeutics Corp. | -4.79 Million USD | -2722.24% |
| Monopar Therapeutics Inc. | -8.83 Million USD | -1431.232% |
| Exelixis, Inc. | 170.88 Million USD | 179.133% |
| Better Therapeutics, Inc. | -38.26 Million USD | -253.423% |
| Nurix Therapeutics, Inc. | -155.06 Million USD | 12.792% |
| Apellis Pharmaceuticals, Inc. | -517.12 Million USD | 73.85% |
| NLS Pharmaceutics AG | -11.8 Million USD | -1045.303% |
| Dermata Therapeutics, Inc. | -8.04 Million USD | -1581.525% |
| Aridis Pharmaceuticals, Inc. | -29.99 Million USD | -350.861% |
| Gritstone bio, Inc. | -154.63 Million USD | 12.551% |
| Jasper Therapeutics, Inc. | -68.86 Million USD | -96.376% |
| TNF Pharmaceuticals, Inc. | -17.12 Million USD | -689.735% |
| Avid Bioservices, Inc. | -18.67 Million USD | -623.989% |
| Insmed Incorporated | -709.62 Million USD | 80.944% |
| Virpax Pharmaceuticals, Inc. | -15.68 Million USD | -761.877% |
| MediWound Ltd. | -15.29 Million USD | -784.412% |
| OmniAb, Inc. | -69.41 Million USD | -94.798% |
| Alector, Inc. | -151.74 Million USD | 10.883% |
| Seres Therapeutics, Inc. | -107.98 Million USD | -25.23% |
| Checkpoint Therapeutics, Inc. | -52.14 Million USD | -159.313% |
| Zai Lab Limited | -366.57 Million USD | 63.111% |
| Revance Therapeutics, Inc. | -316.77 Million USD | 57.312% |
| Aura Biosciences, Inc. | -84.99 Million USD | -59.107% |
| Lyell Immunopharma, Inc. | -245.49 Million USD | 44.918% |
| Immunic, Inc. | -99.22 Million USD | -36.286% |
| Tarsus Pharmaceuticals, Inc. | -143.15 Million USD | 5.54% |
| Veracyte, Inc. | -85.79 Million USD | -57.616% |
| InMed Pharmaceuticals Inc. | - USD | Infinity% |
| FibroGen, Inc. | -281.81 Million USD | 52.016% |
| SeaStar Medical Holding Corporation | -14.21 Million USD | -851.63% |
| Adial Pharmaceuticals, Inc. | -6.88 Million USD | -1863.236% |
| Sonnet BioTherapeutics Holdings, Inc. | -18.79 Million USD | -619.573% |
| Jazz Pharmaceuticals plc | 578.58 Million USD | 123.372% |
| Cyclacel Pharmaceuticals, Inc. | -25.45 Million USD | -431.28% |
| Amylyx Pharmaceuticals, Inc. | 38.8 Million USD | 448.504% |
| TG Therapeutics, Inc. | 20.63 Million USD | 755.39% |
| Galecto, Inc. | -39.9 Million USD | -238.871% |
| Calithera Biosciences, Inc. | -42.07 Million USD | -221.402% |
| Fortrea Holdings Inc. | 63.1 Million USD | 314.305% |
| KalVista Pharmaceuticals, Inc. | -140.44 Million USD | 3.716% |
| Aptevo Therapeutics Inc. | -28.87 Million USD | -368.269% |
| XBiotech Inc. | -37.51 Million USD | -260.508% |
| Jasper Therapeutics, Inc. | -68.86 Million USD | -96.376% |
| Lyra Therapeutics, Inc. | -67.12 Million USD | -101.47% |
| Foghorn Therapeutics Inc. | -107.9 Million USD | -25.319% |
| Y-mAbs Therapeutics, Inc. | -25.67 Million USD | -426.748% |
| Theravance Biopharma, Inc. | -53.29 Million USD | -153.747% |
| Ultragenyx Pharmaceutical Inc. | -569.2 Million USD | 76.243% |
| Metagenomi, Inc. Common Stock | -78.49 Million USD | -72.281% |
| Vaxxinity, Inc. | -58.28 Million USD | -132.009% |
| BioCryst Pharmaceuticals, Inc. | -103.7 Million USD | -30.39% |
| Gain Therapeutics, Inc. | -22.25 Million USD | -507.675% |
| Cartesian Therapeutics, Inc. | -86.41 Million USD | -56.483% |
| NexImmune, Inc. | -29.19 Million USD | -363.224% |
| Creative Medical Technology Holdings, Inc. | -5.62 Million USD | -2306.112% |
| Marker Therapeutics, Inc. | -14.58 Million USD | -827.393% |
| Regeneron Pharmaceuticals, Inc. | 4.04 Billion USD | 103.341% |
| Chemomab Therapeutics Ltd. | -25.45 Million USD | -431.155% |
| Scopus BioPharma Inc. | -11.71 Million USD | -1054.316% |
| RAPT Therapeutics, Inc. | -127.06 Million USD | -6.426% |
| Ainos, Inc. | -13.2 Million USD | -923.948% |
| Pluri Inc. | -22.15 Million USD | -510.284% |
| Prothena Corporation plc | -191.03 Million USD | 29.214% |
| Adaptimmune Therapeutics plc | -138.03 Million USD | 2.037% |
| Celularity Inc. | -192.28 Million USD | 29.675% |
| Rallybio Corporation | -78.93 Million USD | -71.32% |
| Cue Biopharma, Inc. | -52.14 Million USD | -159.308% |
| MeiraGTx Holdings plc | -137.06 Million USD | 1.338% |
| Omeros Corporation | -164.53 Million USD | 17.81% |
| Humacyte, Inc. | -100.04 Million USD | -35.163% |
| Immunocore Holdings plc | -59.64 Million USD | -126.704% |
| Cocrystal Pharma, Inc. | -18.55 Million USD | -628.631% |
| Cidara Therapeutics, Inc. | -24.48 Million USD | -452.329% |
| Blueprint Medicines Corporation | -486.27 Million USD | 72.191% |
| CalciMedica, Inc. | -21.87 Million USD | -518.179% |
| Cabaletta Bio, Inc. | -74.66 Million USD | -81.123% |
| Marinus Pharmaceuticals, Inc. | -131.48 Million USD | -2.846% |
| Scholar Rock Holding Corporation | -171.29 Million USD | 21.056% |
| Sana Biotechnology, Inc. | -326.9 Million USD | 58.634% |
| Pulmatrix, Inc. | -14.74 Million USD | -817.413% |
| Elicio Therapeutics, Inc. | -35.74 Million USD | -278.309% |
| Vigil Neuroscience, Inc. | -88.86 Million USD | -52.169% |
| Intellia Therapeutics, Inc. | -515.29 Million USD | 73.757% |
| Adlai Nortye Ltd. American Depositary Shares | -67.55 Million USD | -100.185% |
| Cytokinetics, Incorporated | -496.2 Million USD | 72.748% |
| Eloxx Pharmaceuticals, Inc. | -34.41 Million USD | -292.884% |
| Nutriband Inc. | -4.87 Million USD | -2675.63% |
| Protara Therapeutics, Inc. | -43.61 Million USD | -210.06% |
| Vor Biopharma Inc. | -126.03 Million USD | -7.292% |
| Roivant Sciences Ltd. | 4.24 Billion USD | 103.188% |
| Evogene Ltd. | -26.39 Million USD | -412.397% |
| ProKidney Corp. | -151.52 Million USD | 10.754% |
| Applied Therapeutics, Inc. | -64.53 Million USD | -109.54% |
| Hoth Therapeutics, Inc. | -7.69 Million USD | -1657.962% |
| BridgeBio Pharma, Inc. | -607.37 Million USD | 77.736% |
| CorMedix Inc. | -48.95 Million USD | -176.211% |
| BioLineRx Ltd. | -49.69 Million USD | -172.119% |
| Tango Therapeutics, Inc. | -114.17 Million USD | -18.44% |
| Galectin Therapeutics Inc. | -38.07 Million USD | -255.187% |
| Atai Life Sciences N.V. | -125.47 Million USD | -7.775% |
| Renovaro Biosciences Inc. | -81.63 Million USD | -65.639% |
| Aerovate Therapeutics, Inc. | -81.4 Million USD | -66.108% |
| Zentalis Pharmaceuticals, Inc. | -248.98 Million USD | 45.689% |
| Sagimet Biosciences Inc. | -30.74 Million USD | -339.905% |
| MediciNova, Inc. | -9.9 Million USD | -1265.889% |
| Praxis Precision Medicines, Inc. | -126.37 Million USD | -7.006% |
| Cardio Diagnostics Holdings, Inc. | -7.24 Million USD | -1767.137% |
| GeoVax Labs, Inc. | -26.74 Million USD | -405.654% |
| Axsome Therapeutics, Inc. | -231.82 Million USD | 41.669% |
| Biomea Fusion, Inc. | -126.13 Million USD | -7.208% |
| PTC Therapeutics, Inc. | -349.4 Million USD | 61.298% |
| Mereo BioPharma Group plc | -28.41 Million USD | -375.882% |
| Cullinan Oncology, Inc. | -191.08 Million USD | 29.234% |
| Syndax Pharmaceuticals, Inc. | -229.95 Million USD | 41.194% |
| Absci Corporation | -115.51 Million USD | -17.064% |
| NRx Pharmaceuticals, Inc. | -27.58 Million USD | -390.183% |
| 4D Molecular Therapeutics, Inc. | -112.86 Million USD | -19.811% |
| Dyne Therapeutics, Inc. | -242.16 Million USD | 44.159% |
| Kiniksa Pharmaceuticals, Ltd. | -25.19 Million USD | -436.699% |
| Ventyx Biosciences, Inc. | -207.99 Million USD | 34.985% |
| Allakos Inc. | -196.05 Million USD | 31.027% |
| Imunon, Inc. | -21.03 Million USD | -543.005% |
| Fulcrum Therapeutics, Inc. | -110.66 Million USD | -22.196% |
| Corcept Therapeutics Incorporated | 107.28 Million USD | 226.048% |
| BioAtla, Inc. | -129.68 Million USD | -4.272% |
| NLS Pharmaceutics AG | -11.8 Million USD | -1045.303% |
| Bio-Path Holdings, Inc. | -15.84 Million USD | -753.542% |
| Allogene Therapeutics, Inc. | -327.73 Million USD | 58.739% |
| Larimar Therapeutics, Inc. | -41.75 Million USD | -223.834% |
| XOMA Corporation | -41.84 Million USD | -223.138% |
| Kezar Life Sciences, Inc. | -105.23 Million USD | -28.497% |
| Cara Therapeutics, Inc. | -121.49 Million USD | -11.302% |
| aTyr Pharma, Inc. | -54.91 Million USD | -146.229% |
| Aligos Therapeutics, Inc. | -87.42 Million USD | -54.674% |
| Akero Therapeutics, Inc. | -172.87 Million USD | 21.776% |
| Viridian Therapeutics, Inc. | -254.45 Million USD | 46.855% |
| Eliem Therapeutics, Inc. | -21.46 Million USD | -529.957% |
| EyeGate Pharmaceuticals, Inc. | -8.21 Million USD | -1546.544% |
| Akari Therapeutics, Plc | -16.8 Million USD | -704.633% |
| Tevogen Bio Holdings Inc. | -8843.03 USD | -1529089.169% |
| Halozyme Therapeutics, Inc. | 337.57 Million USD | 140.058% |
| Lexaria Bioscience Corp. | -6.53 Million USD | -1969.578% |
| UroGen Pharma Ltd. | -65.53 Million USD | -106.34% |
| Sutro Biopharma, Inc. | -89.27 Million USD | -51.467% |
| ZIVO Bioscience, Inc. | -7.26 Million USD | -1761.854% |
| Orgenesis Inc. | -53.63 Million USD | -152.119% |
| Entera Bio Ltd. | -8.89 Million USD | -1420.939% |
| GH Research PLC | -41.22 Million USD | -228.045% |
| Lisata Therapeutics, Inc. | -25.7 Million USD | -426.01% |
| Reneo Pharmaceuticals, Inc. | -83.05 Million USD | -62.82% |
| Xencor, Inc. | -138.63 Million USD | 2.461% |
| 60 Degrees Pharmaceuticals, Inc. | -5.15 Million USD | -2523.426% |
| Replimune Group, Inc. | -234.77 Million USD | 42.401% |
| Coeptis Therapeutics Holdings, Inc. | -21.49 Million USD | -529.221% |
| Vanda Pharmaceuticals Inc. | -13.95 Million USD | -869.228% |
| Lexaria Bioscience Corp. | -6.53 Million USD | -1969.578% |
| Portage Biotech Inc. | -18.25 Million USD | -640.846% |
| Cardio Diagnostics Holdings, Inc. | -7.24 Million USD | -1767.137% |
| Olema Pharmaceuticals, Inc. | -104.96 Million USD | -28.835% |
| OncoCyte Corporation | -25.13 Million USD | -437.98% |
| Qualigen Therapeutics, Inc. | -11.3 Million USD | -1096.182% |
| Processa Pharmaceuticals, Inc. | -11.45 Million USD | -1080.291% |
| Purple Biotech Ltd. | 22.27 Million USD | 707.187% |
| CollPlant Biotechnologies Ltd. | -7.51 Million USD | -1700.142% |
| scPharmaceuticals Inc. | -55.39 Million USD | -144.109% |
| ProMIS Neurosciences, Inc. | -18.89 Million USD | -615.572% |
| HilleVax, Inc. | -133.34 Million USD | -1.411% |
| NeuroSense Therapeutics Ltd. | -12.04 Million USD | -1022.306% |
| Tharimmune, Inc. | -9.45 Million USD | -1330.18% |
| Genprex, Inc. | -31.07 Million USD | -335.154% |
| Neumora Therapeutics, Inc. Common Stock | -188.19 Million USD | 28.145% |
| Atossa Therapeutics, Inc. | -31.37 Million USD | -330.974% |
| XTL Biopharmaceuticals Ltd. | -765 Thousand USD | -17576.687% |
| Virios Therapeutics, Inc. | -5.44 Million USD | -2382.627% |
| OKYO Pharma Limited | -15.74 Thousand USD | -858496.668% |
| Savara Inc. | -60 Million USD | -125.351% |
| Curis, Inc. | -48.33 Million USD | -179.787% |
| Daré Bioscience, Inc. | -30.83 Million USD | -338.48% |
| Carmell Therapeutics Corporation | -5.21 Million USD | -2491.9% |
| Titan Pharmaceuticals, Inc. | -7.27 Million USD | -1758.275% |
| Achieve Life Sciences, Inc. | -27.25 Million USD | -396.245% |
| BeiGene, Ltd. | -1.2 Billion USD | 88.803% |
| Kiromic BioPharma, Inc. | -19.93 Million USD | -578.192% |
| Revolution Medicines, Inc. Warrant | -487.18 Million USD | 72.243% |
| Protagonist Therapeutics, Inc. | -93.65 Million USD | -44.393% |
| Erasca, Inc. | -141.52 Million USD | 4.45% |
| bluebird bio, Inc. | -244.26 Million USD | 44.639% |
| Protagenic Therapeutics, Inc. | -4.52 Million USD | -2887.131% |
| BioMarin Pharmaceutical Inc. | 194.44 Million USD | 169.546% |
| DBV Technologies S.A. | -76.43 Million USD | -76.924% |
| Protagenic Therapeutics, Inc. | -4.52 Million USD | -2887.131% |
| Moderna, Inc. | -4.23 Billion USD | 96.81% |
| Vincerx Pharma, Inc. | -42.6 Million USD | -217.366% |
| Fresh Tracks Therapeutics, Inc. | -6.36 Million USD | -2026.205% |
| Molecular Templates, Inc. | -10.46 Million USD | -1192.057% |
| Acrivon Therapeutics, Inc. Common Stock | -67.23 Million USD | -101.119% |
| Travere Therapeutics, Inc. | -376.74 Million USD | 64.106% |
| Monte Rosa Therapeutics, Inc. | -143.31 Million USD | 5.641% |
| Spruce Biosciences, Inc. | -51.99 Million USD | -160.086% |
| Celldex Therapeutics, Inc. | -154.54 Million USD | 12.498% |
| Cogent Biosciences, Inc. | -208.13 Million USD | 35.028% |
| MacroGenics, Inc. | -168.24 Million USD | 19.625% |
| RenovoRx, Inc. | -11.39 Million USD | -1086.615% |
| Adicet Bio, Inc. | -152.03 Million USD | 11.057% |
| Prime Medicine, Inc. | -191.29 Million USD | 29.309% |
| Aditxt, Inc. | -26.06 Million USD | -418.857% |
| Adagene Inc. | -23.71 Million USD | -470.099% |
| Estrella Immunopharma, Inc. | -7.31 Million USD | -1749.861% |
| Quantum-Si incorporated | -111.17 Million USD | -21.638% |
| Maravai LifeSciences Holdings, Inc. | -31.64 Million USD | -327.283% |
| Acurx Pharmaceuticals, Inc. | -14.57 Million USD | -827.623% |
| Voyager Therapeutics, Inc. | 122.01 Million USD | 210.829% |
| SciSparc Ltd. | -5.77 Million USD | -2242.398% |
| Vericel Corporation | -6.46 Million USD | -1991.997% |
| Revelation Biosciences, Inc. | -8.65 Million USD | -1462.11% |
| Minerva Neurosciences, Inc. | -23.11 Million USD | -484.901% |
| Generation Bio Co. | -138.56 Million USD | 2.408% |
| Astria Therapeutics, Inc. | -83.03 Million USD | -62.865% |
| Black Diamond Therapeutics, Inc. | -86.46 Million USD | -56.404% |
| Arcutis Biotherapeutics, Inc. | -241.1 Million USD | 43.913% |
| Invivyd, Inc. | -207.78 Million USD | 34.919% |
| Relay Therapeutics, Inc. | -373 Million USD | 63.746% |
| Quoin Pharmaceuticals, Ltd. | -9.37 Million USD | -1341.879% |
| Spero Therapeutics, Inc. | 21.48 Million USD | 729.518% |
| Artelo Biosciences, Inc. | -10.28 Million USD | -1214.539% |
| 2seventy bio, Inc. | -216.7 Million USD | 37.598% |
| ADMA Biologics, Inc. | 21.63 Million USD | 725.123% |
| Clene Inc. | -40.54 Million USD | -233.564% |
| Capricor Therapeutics, Inc. | -24.07 Million USD | -461.622% |
| Boundless Bio, Inc. Common Stock | -54.79 Million USD | -146.782% |
| GeoVax Labs, Inc. | -26.74 Million USD | -405.654% |
| Recursion Pharmaceuticals, Inc. | -350.06 Million USD | 61.37% |
| Citius Pharmaceuticals, Inc. | -36.73 Million USD | -268.144% |
| Contineum Therapeutics, Inc. Class A Common Stock | 16.07 Million USD | 941.119% |
| Relmada Therapeutics, Inc. | -103.7 Million USD | -30.399% |
| Finch Therapeutics Group, Inc. | -34 Million USD | -297.702% |
| ALX Oncology Holdings Inc. | -170.27 Million USD | 20.585% |
| Vir Biotechnology, Inc. | -684.3 Million USD | 80.239% |
| Evaxion Biotech A/S | -22.19 Million USD | -509.211% |
| Ocular Therapeutix, Inc. | -82.38 Million USD | -64.146% |
| Verve Therapeutics, Inc. | -223.12 Million USD | 39.394% |
| Trevena, Inc. | -35.28 Million USD | -283.209% |
| Surrozen, Inc. | -45.78 Million USD | -195.384% |
| Tyra Biosciences, Inc. | -79.94 Million USD | -69.15% |
| Cingulate Inc. | -22.75 Million USD | -494.163% |
| Galmed Pharmaceuticals Ltd. | 7.49 Million USD | 1904.947% |
| Unity Biotechnology, Inc. | -44.66 Million USD | -202.744% |
| Tenax Therapeutics, Inc. | -8.23 Million USD | -1542.308% |
| Terns Pharmaceuticals, Inc. | -102.55 Million USD | -31.854% |
| ACADIA Pharmaceuticals Inc. | -73.37 Million USD | -84.285% |
| Connect Biopharma Holdings Limited | -62.07 Million USD | -117.847% |
| Clearmind Medicine Inc. | -8.74 Million USD | -1446.977% |
| Kronos Bio, Inc. | -121.83 Million USD | -10.996% |
| Bolt Biotherapeutics, Inc. | -76.19 Million USD | -77.472% |
| CERo Therapeutics Holdings, Inc. | -2.93 Million USD | -4510.547% |
| Viking Therapeutics, Inc. | -100.82 Million USD | -34.118% |
| Statera Biopharma, Inc. | -98.34 Million USD | -37.504% |
| ImmunityBio, Inc. | -362.25 Million USD | 62.67% |
| Korro Bio, Inc. | -84.53 Million USD | -59.967% |
| Kineta, Inc. | -15.72 Million USD | -760.056% |
| BioVie Inc. | -32.17 Million USD | -320.225% |
| Codexis, Inc. | -68.06 Million USD | -98.661% |
| Celularity Inc. | -192.28 Million USD | 29.675% |
| Crinetics Pharmaceuticals, Inc. | -222.6 Million USD | 39.253% |
| Celcuity Inc. | -66.23 Million USD | -104.176% |
| Virax Biolabs Group Limited | -6.49 Million USD | -1981.54% |
| Cibus, Inc. | -318.88 Million USD | 57.594% |
| Eledon Pharmaceuticals, Inc. | -43 Million USD | -214.481% |
| eFFECTOR Therapeutics, Inc. | -33.84 Million USD | -299.559% |
| IN8bio, Inc. | -30.33 Million USD | -345.748% |
| Kodiak Sciences Inc. | -277.32 Million USD | 51.238% |
| Annexon, Inc. | -143.72 Million USD | 5.912% |
| Adverum Biotechnologies, Inc. | -123.79 Million USD | -9.238% |
| Assembly Biosciences, Inc. | -64.64 Million USD | -109.18% |
| Avalo Therapeutics, Inc. | -23.44 Million USD | -476.807% |
| Ionis Pharmaceuticals, Inc. | -353.73 Million USD | 61.771% |
| Eyenovia, Inc. | -25.4 Million USD | -432.253% |
| Puma Biotechnology, Inc. | 32.64 Million USD | 514.297% |
| Conduit Pharmaceuticals Inc. | -5.56 Million USD | -2331.26% |
| Xilio Therapeutics, Inc. | -79.13 Million USD | -70.885% |
| Arcellx, Inc. | -89.88 Million USD | -50.452% |
| Cardiff Oncology, Inc. | -45.41 Million USD | -197.777% |
| Enanta Pharmaceuticals, Inc. | -137.2 Million USD | 1.443% |
| Regulus Therapeutics Inc. | -31.1 Million USD | -334.687% |
| Moolec Science SA | -6.65 Million USD | -1932.321% |
| Acumen Pharmaceuticals, Inc. | -61.13 Million USD | -121.183% |
| Geron Corporation | -193.94 Million USD | 30.275% |
| LAVA Therapeutics N.V. | -43.25 Million USD | -212.641% |
| Royalty Pharma plc | 1.49 Billion USD | 109.063% |
| Atea Pharmaceuticals, Inc. | -164.16 Million USD | 17.626% |
| Greenwich LifeSciences, Inc. | -9.32 Million USD | -1349.706% |
| TFF Pharmaceuticals, Inc. | -21.89 Million USD | -517.624% |
| Mersana Therapeutics, Inc. | -170.95 Million USD | 20.9% |
| Humacyte, Inc. | -100.04 Million USD | -35.163% |
| Structure Therapeutics Inc. | -102.77 Million USD | -31.575% |
| 89bio, Inc. | -151.2 Million USD | 10.567% |
| PMV Pharmaceuticals, Inc. | -80.13 Million USD | -68.755% |
| Avenue Therapeutics, Inc. | -14.54 Million USD | -830.032% |
| Genelux Corporation | -24.16 Million USD | -459.597% |
| Trevi Therapeutics, Inc. | -33.92 Million USD | -298.628% |
| Lexicon Pharmaceuticals, Inc. | -171.75 Million USD | 21.265% |
| Notable Labs, Ltd. | -14.65 Million USD | -822.608% |
| Liquidia Corporation | -73.38 Million USD | -84.273% |
| Mustang Bio, Inc. | -50.72 Million USD | -166.583% |
| Immunovant, Inc. | -282.7 Million USD | 52.168% |
| Quantum-Si incorporated | -111.17 Million USD | -21.638% |
| Arbutus Biopharma Corporation | -78.1 Million USD | -73.139% |
| DiaMedica Therapeutics Inc. | -21.26 Million USD | -535.852% |
| Vera Therapeutics, Inc. | -102.01 Million USD | -32.56% |
| Acasti Pharma Inc. | -11.31 Million USD | -1095.427% |
| MiNK Therapeutics, Inc. | -22.92 Million USD | -489.966% |
| Pasithea Therapeutics Corp. | -15.97 Million USD | -746.258% |
| Xenon Pharmaceuticals Inc. | -214.05 Million USD | 36.826% |
| Elevai Labs, Inc. Common Stock | -3.66 Million USD | -3585.582% |
| NeuroBo Pharmaceuticals, Inc. | -15.88 Million USD | -751.232% |
| Tempest Therapeutics, Inc. | -29.15 Million USD | -363.788% |
| Soleno Therapeutics, Inc. | -41.38 Million USD | -226.761% |
| PepGen Inc. | -84.76 Million USD | -59.529% |
| Moleculin Biotech, Inc. | -29.63 Million USD | -356.369% |
| United Therapeutics Corporation | 1.18 Billion USD | 111.412% |
| Nuvectis Pharma, Inc. | -22.89 Million USD | -490.587% |
| Solid Biosciences Inc. | -104.31 Million USD | -29.633% |
| BriaCell Therapeutics Corp. | -32.8 Million USD | -312.174% |
| Immuneering Corporation | -58.41 Million USD | -131.501% |
| Lixte Biotechnology Holdings, Inc. | -5.09 Million USD | -2556.589% |
| Silo Pharma, Inc. | -3.85 Million USD | -3407.286% |
| Belite Bio, Inc | -31.66 Million USD | -327.014% |
| XOMA Corporation | -41.84 Million USD | -223.138% |
| ARS Pharmaceuticals, Inc. | -67.52 Million USD | -100.276% |
| Bionomics Limited | -17.89 Billion USD | 99.244% |
| Apogee Therapeutics, Inc. | -93 Million USD | -45.4% |
| Alpha Tau Medical Ltd. | 35.68 Million USD | 478.998% |
| uniQure N.V. | -282.87 Million USD | 52.195% |
| Cassava Sciences, Inc. | -105.95 Million USD | -27.624% |
| Estrella Immunopharma, Inc. | -7.31 Million USD | -1749.861% |
| Poseida Therapeutics, Inc. | -129.5 Million USD | -4.419% |
| Forte Biosciences, Inc. | -32.48 Million USD | -316.261% |
| Anebulo Pharmaceuticals, Inc. | -8.3 Million USD | -1527.52% |
| Enlivex Therapeutics Ltd. | -29.39 Million USD | -360.033% |
| Conduit Pharmaceuticals Inc. | -5.56 Million USD | -2331.26% |
| SeaStar Medical Holding Corporation | -14.21 Million USD | -851.63% |
| FibroBiologics, Inc. Common Stock | -8.88 Million USD | -1421.281% |
| Altimmune, Inc. | -95.92 Million USD | -40.965% |
| Amicus Therapeutics, Inc. | -73.49 Million USD | -83.997% |
| Alpha Tau Medical Ltd. | 35.68 Million USD | 478.998% |
| Compugen Ltd. | -12.99 Million USD | -940.846% |
| Peak Bio, Inc. | -1356.23 USD | -9970676.122% |
| Zevra Therapeutics, Inc. | -49.6 Million USD | -172.612% |
| Benitec Biopharma Inc. | -22.49 Million USD | -501.275% |
| Spyre Therapeutics, Inc. | -242.3 Million USD | 44.191% |
| NKGen Biotech, Inc. Common Stock | -29.74 Million USD | -354.605% |
| Zura Bio Limited | -62.63 Million USD | -115.886% |
| PolyPid Ltd. | -22.86 Million USD | -491.362% |
| Aileron Therapeutics, Inc. | -16.27 Million USD | -730.835% |
| NKGen Biotech, Inc. Warrants | -29.74 Million USD | -354.605% |
| Instil Bio, Inc. | -159.16 Million USD | 15.042% |
| argenx SE | -425.04 Million USD | 68.186% |
| Immunome, Inc. | -109.53 Million USD | -23.461% |
| Compass Therapeutics, Inc. | -50.36 Million USD | -168.504% |
| Verona Pharma plc | -67.83 Million USD | -99.358% |
| enGene Holdings Inc. Warrants | -26.06 Million USD | -418.905% |
| Shattuck Labs, Inc. | -91.95 Million USD | -47.054% |
| CervoMed Inc. | -7.81 Million USD | -1630.814% |
| LENZ Therapeutics, Inc. | -73.11 Million USD | -84.963% |
| Plus Therapeutics, Inc. | -13.32 Million USD | -915.139% |
| Dianthus Therapeutics, Inc. | -48.17 Million USD | -180.705% |
| Moolec Science SA | -6.65 Million USD | -1932.321% |
| Enveric Biosciences, Inc. | -16.44 Million USD | -722.125% |
| AnaptysBio, Inc. | -164.41 Million USD | 17.751% |
| Design Therapeutics, Inc. | -78.19 Million USD | -72.946% |
| Leap Therapeutics, Inc. | -87.04 Million USD | -55.36% |
| NeurAxis, Inc. | -6.66 Million USD | -1929.061% |
| Seelos Therapeutics, Inc. | -40.49 Million USD | -233.901% |
| Lumos Pharma, Inc. | -36.61 Million USD | -269.33% |
| Achilles Therapeutics plc | -75.25 Million USD | -79.691% |
| enGene Holdings Inc. Common Stock | -26.06 Million USD | -418.905% |
| 180 Life Sciences Corp. | -13.47 Million USD | -903.351% |
| Opiant Pharmaceuticals, Inc. | 5.15 Million USD | 2722.547% |
| CERo Therapeutics Holdings, Inc. | -2.93 Million USD | -4510.547% |
| Nutriband Inc. | -4.87 Million USD | -2675.63% |
| ORIC Pharmaceuticals, Inc. | -110.78 Million USD | -22.068% |
| CG Oncology, Inc. Common stock | -55.44 Million USD | -143.876% |
| Fractyl Health, Inc. Common Stock | -50.83 Million USD | -166.006% |
| Rani Therapeutics Holdings, Inc. | -66.09 Million USD | -104.582% |
| MoonLake Immunotherapeutics | -54.12 Million USD | -149.85% |
| Palisade Bio, Inc. | -13.07 Million USD | -934.634% |
| Tourmaline Bio, Inc. | -45.4 Million USD | -197.797% |
| Beam Therapeutics Inc. | -176.48 Million USD | 23.378% |
| Neurogene Inc. | -55.58 Million USD | -143.288% |
| Mirum Pharmaceuticals, Inc. | -109.15 Million USD | -23.886% |
| AEON Biopharma, Inc. | -48.42 Million USD | -179.227% |
| CARGO Therapeutics, Inc. Common Stock | -96.71 Million USD | -39.827% |
| Sesen Bio, Inc. | -25.9 Million USD | -421.929% |
| Enliven Therapeutics, Inc. | -83.52 Million USD | -61.892% |
| Kiora Pharmaceuticals, Inc. | -12.58 Million USD | -974.345% |
| Iovance Biotherapeutics, Inc. | -460.55 Million USD | 70.639% |
| Taysha Gene Therapies, Inc. | -72.43 Million USD | -86.677% |
| Athira Pharma, Inc. | -125.46 Million USD | -7.78% |
| Vaccinex, Inc. | -22.88 Million USD | -490.896% |
| HCW Biologics Inc. | -25.71 Million USD | -425.823% |
| XOMA Corporation | -41.84 Million USD | -223.138% |
| Nektar Therapeutics | -137.42 Million USD | 1.6% |
| Arvinas, Inc. | -401.5 Million USD | 66.32% |
| Tevogen Bio Holdings Inc. | -8843.03 USD | -1529089.169% |
| Merus N.V. | -156.54 Million USD | 13.619% |
| Omega Therapeutics, Inc. | -100.26 Million USD | -34.875% |
| Quince Therapeutics, Inc. | -34.62 Million USD | -290.603% |
| Rezolute, Inc. | -70.42 Million USD | -92.021% |
| Clene Inc. | -40.54 Million USD | -233.564% |
| Indaptus Therapeutics, Inc. | -16.37 Million USD | -725.636% |
| BeyondSpring Inc. | -23.11 Million USD | -485.042% |
| Synlogic, Inc. | -55.16 Million USD | -145.149% |
| Allarity Therapeutics, Inc. | -17.92 Million USD | -654.234% |
| Phio Pharmaceuticals Corp. | -10.82 Million USD | -1149.322% |
| Peak Bio, Inc. | -1356.23 USD | -9970676.122% |
| Werewolf Therapeutics, Inc. | -40.5 Million USD | -233.868% |
| Krystal Biotech, Inc. | -109.72 Million USD | -23.239% |
| Karyopharm Therapeutics Inc. | -129.53 Million USD | -4.39% |
| SpringWorks Therapeutics, Inc. | -343.01 Million USD | 60.577% |
| Lipella Pharmaceuticals Inc. | -4.74 Million USD | -2749.305% |
| MannKind Corporation | 8.67 Million USD | 1658.27% |
| Ikena Oncology, Inc. | -75.41 Million USD | -79.305% |
| Cyclerion Therapeutics, Inc. | -9.64 Million USD | -1301.748% |
| Gyre Therapeutics, Inc. | -67.23 Million USD | -101.14% |
| Gossamer Bio, Inc. | -183.75 Million USD | 26.411% |
| CohBar, Inc. | -12.38 Million USD | -991.568% |
| Cognition Therapeutics, Inc. | -50.72 Million USD | -166.593% |
| NRx Pharmaceuticals, Inc. | -27.58 Million USD | -390.183% |
| Legend Biotech Corporation | -439.48 Million USD | 69.231% |
| Mural Oncology plc | -194.63 Million USD | 30.524% |
| Biora Therapeutics, Inc. | -67.14 Million USD | -101.401% |
| PaxMedica, Inc. Common Stock | -16.14 Million USD | -737.562% |
| Disc Medicine, Inc. | -91.12 Million USD | -48.397% |
| Champions Oncology, Inc. | -7.35 Million USD | -1738.318% |
| REGENXBIO Inc. | -268.12 Million USD | 49.566% |
| Ensysce Biosciences, Inc. | -10.71 Million USD | -1161.656% |
| Anavex Life Sciences Corp. | -55.75 Million USD | -142.533% |
| Cellectar Biosciences, Inc. | -38.96 Million USD | -247.085% |
| Edgewise Therapeutics, Inc. | -114.35 Million USD | -18.25% |
| Vaxart, Inc. | -83.34 Million USD | -62.245% |
| PharmaCyte Biotech, Inc. | -8.52 Million USD | -1487.166% |
| Aldeyra Therapeutics, Inc. | -42.79 Million USD | -215.994% |
| Cellectis S.A. | -106.62 Million USD | -26.823% |
| Longeveron Inc. | -21.02 Million USD | -543.048% |
| Repare Therapeutics Inc. | -116.22 Million USD | -16.35% |
| Sarepta Therapeutics, Inc. | -267.82 Million USD | 49.509% |
| Inozyme Pharma, Inc. | -75.64 Million USD | -78.765% |
| Revolution Medicines, Inc. | -487.18 Million USD | 72.243% |
| Nymox Pharmaceutical Corporation | -6.65 Million USD | -1932.872% |
| Third Harmonic Bio, Inc. | -43.95 Million USD | -207.655% |
| ArriVent BioPharma, Inc. Common Stock | -74.59 Million USD | -81.293% |
| AN2 Therapeutics, Inc. | -69.63 Million USD | -94.194% |
| Anixa Biosciences, Inc. | -11.01 Million USD | -1128.105% |
| Vertex Pharmaceuticals Incorporated | 4.3 Billion USD | 103.139% |
| Denali Therapeutics Inc. | -196.69 Million USD | 31.252% |
| Revelation Biosciences, Inc. | -8.65 Million USD | -1462.11% |
| Veru Inc. | -93.78 Million USD | -44.192% |
| Corvus Pharmaceuticals, Inc. | -23.32 Million USD | -479.65% |
| Cingulate Inc. | -22.75 Million USD | -494.163% |
| Passage Bio, Inc. | -108.38 Million USD | -24.76% |
| Context Therapeutics Inc. | -25.07 Million USD | -439.34% |
| Exicure, Inc. | -14.99 Million USD | -801.752% |
| Day One Biopharmaceuticals, Inc. | -206.06 Million USD | 34.376% |
| Oramed Pharmaceuticals Inc. | -40.59 Million USD | -233.087% |
| Scinai Immunotherapeutics Ltd. | -9.71 Million USD | -1291.659% |
| Rhythm Pharmaceuticals, Inc. | -184.35 Million USD | 26.65% |
| Nuvalent, Inc. | -149.49 Million USD | 9.543% |
| ABVC BioPharma, Inc. | -8.21 Million USD | -1545.792% |
| Carisma Therapeutics, Inc. | -88.73 Million USD | -52.401% |
| Unicycive Therapeutics, Inc. | -20.77 Million USD | -550.942% |
| OmniAb, Inc. | -69.41 Million USD | -94.798% |
| Anew Medical, Inc. | -1.3 Million USD | -10295.334% |
| Fennec Pharmaceuticals Inc. | -12.77 Million USD | -958.857% |
| Lipocine Inc. | -17.93 Million USD | -654.152% |
| Lexeo Therapeutics, Inc. Common Stock | -68.51 Million USD | -97.374% |
| Nautilus Biotechnology, Inc. | -76.15 Million USD | -77.575% |
| SAB Biotherapeutics, Inc. | -38.07 Million USD | -255.156% |
| G1 Therapeutics, Inc. | -39.52 Million USD | -242.112% |
| Bellerophon Therapeutics, Inc. | -22.38 Million USD | -504.122% |
| Sage Therapeutics, Inc. | -579.84 Million USD | 76.679% |
| Ocugen, Inc. | -65.53 Million USD | -106.355% |
| Mind Medicine (MindMed) Inc. | -93.86 Million USD | -44.064% |
| Q32 Bio Inc. | -92.1 Million USD | -46.823% |
| Brainstorm Cell Therapeutics Inc. | -21.43 Million USD | -530.751% |
| Alumis Inc. Common Stock | -158.17 Million USD | 14.508% |
| Equillium, Inc. | -14.52 Million USD | -831.185% |
| Kyverna Therapeutics, Inc. | -62.4 Million USD | -116.689% |
| Coya Therapeutics, Inc. | -7.9 Million USD | -1611.004% |
| CNS Pharmaceuticals, Inc. | -18.86 Million USD | -616.808% |
| Galera Therapeutics, Inc. | -46.95 Million USD | -188.017% |
| Evelo Biosciences, Inc. | -108.46 Million USD | -24.672% |
| Comera Life Sciences Holdings, Inc. | -11.97 Million USD | -1029.712% |
| Dominari Holdings Inc. | -21.79 Million USD | -520.42% |
| Edesa Biotech, Inc. | -9.22 Million USD | -1366.228% |
| vTv Therapeutics Inc. | -25.5 Million USD | -430.259% |
| Bio-Techne Corporation | 206.68 Million USD | 165.426% |
| Agios Pharmaceuticals, Inc. | -391.48 Million USD | 65.458% |
| Harmony Biosciences Holdings, Inc. | 192.03 Million USD | 170.42% |
| Prelude Therapeutics Incorporated | -132.27 Million USD | -2.23% |
| Candel Therapeutics, Inc. | -38.39 Million USD | -252.235% |
| iTeos Therapeutics, Inc. | -151.1 Million USD | 10.506% |
| Nkarta, Inc. | -131.65 Million USD | -2.717% |
| BioCardia, Inc. | -11.64 Million USD | -1061.342% |
| Iterum Therapeutics plc | -47.46 Million USD | -184.88% |